bioRxivMolecular BiologyPreprint
NRF2 pathway activation reverts high-glucose-induced transcriptional memory in endothelial cells
Martí Wilson-VerdugoiD, Brandon Bustos-GarcíaiD, Olga Adame-Guerrero, Jaqueline Hersch-GonzáleziD, Nallely Cano-DomíngueziD, Maribel Soto-NavaiD, Carlos A. Acosta, Teresa Tusié‐LunaiD, Santiago Ávila‐RíosiD, Lilia Guadalupe NoriegaiD, Víctor Julián ValdésiD
Abstract
Various diabetes complications, including nephropathy, retinopathy, and cardiovascular disease, arise from vascular dysfunction. In this context, it has been observed that past hyperglycaemic events can induce long-lasting transcriptional changes, a phenomenon termed "metabolic memory". Yet, the underlying mechanisms driving these persistent effects are not fully characterized. In this study, we evaluated the genome-wide gene expression and chromatin accessibility alterations caused by transient high glucose exposure in human endothelial cells (ECs). We found that cells exposed to a transient high glucose episode had decreased glycolytic and oxygen consumption rates. Transcriptional profiling indicated that high glucose exposure induced substantial changes in the expression of genes belonging to pathways known to be impaired in diabetes, such as TGF-beta, TNF, FoxO, p53, and NRF2 pathways, many of which were retained after normalization of glucose concentrations. Furthermore, analysis of chromatin accessibility showed that transient hyperglycaemia can induce persistent modifications in the accessibility landscape, with the majority of differentially accessible regions located in non-promoter regions. Some of these regions were identified as putative enhancers with neighbouring genes persistently altered after transient high glucose exposure. Finally, we showed that activation of the NRF2 pathway through either NRF2 overexpression or supplementation with the plant-derived compound sulforaphane, was able to substantially revert the glucose-induced transcriptional memory in ECs. Our findings demonstrate that transient high glucose can induce persistent changes in both the transcriptomic and chromatin accessibility profiles of ECs, and that pharmacological NRF2 pathway activation is able to prevent and revert the high-glucose-induced transcriptional memory. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=173 SRC="FIGDIR/small/557207v1_ufig1.gif" ALT="Figure 1"> View larger version (47K): org.highwire.dtl.DTLVardef@b9c938org.highwire.dtl.DTLVardef@1498a43org.highwire.dtl.DTLVardef@1146ab5org.highwire.dtl.DTLVardef@169bfca_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: bulk RNA-seq
- assay: ATAC-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transient high glucose causes delayed wound healing by the DNMT1-mediated Ang-1/NF-κB pathway
- High glucose treatment induced nuclei aggregation of microvascular endothelial cells via foxo1a-klf2a pathway
Xiaoning Wang, Xinyi Kang, … Dong Liu·Arteriosclerosis Thrombosis and Vascular BiologyPeer-reviewed·Jan 30, 2025
- Analysis of the transcriptome and DNA methylome in response to acute and recurrent low glucose in human primary astrocytes
Paul G. Weightman Potter, Sam J. Washer, … Craig Beall·bioRxiv·Jul 7, 2020
- NRF2 activation in the heart induces glucose metabolic reprogramming and mediates cardioprotection via upregulation of the pentose phosphate pathway.
A. Zoccarato, I. Smyrnias, … A. M. Shah·bioRxiv·May 12, 2023
- Nrf2 prevents diabetic cardiomyopathy via antioxidation and normalization of glucose and lipid metabolism in the heart
Ge Yang, Qihe Zhang, … Ying Xin·bioRxiv·Apr 4, 2022
- Dynamic changes in β-cell electrical activity and regulates NFATc3 activation and downstream gene transcription
J. G. Miranda, W. E. Schleicher, … R. K. Benninger·bioRxiv·Jun 28, 2020